Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2
| Inventor | Institute |
|---|---|
| Ingram Iaccarino | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151652 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction |
| Application: | WB |
| Target: | PRAF2 |
| Reactivity: | Mouse |
| Clone: | SG36 |
| Host: | Rabbit |
| Class: | Polyclonal |
| Product description: | Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2 |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | Recombinant full-length Praf2 of human origin fused to GST |
| Target background: | Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2 |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | Whole serum |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.